PROPHASE GLOBAL HEALTHCARE Trademark

Trademark Overview


On Saturday, June 5, 2021, a trademark application was filed for PROPHASE GLOBAL HEALTHCARE with the United States Patent and Trademark Office. The USPTO has given the PROPHASE GLOBAL HEALTHCARE trademark a serial number of 90756650. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, May 30, 2024. This trademark is owned by ProPhase Labs, Inc.. The PROPHASE GLOBAL HEALTHCARE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Vaccines and medical preparations for use in the treatment and prevention of Covid-19, flu and related respiratory and medical conditions; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids; diagnostic reagents for medicinal use; diagnostic biomarker reagents for medical purposes; medical diagnostic reagents and assays for testing body fluids for microorganisms; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents for the analysis of body fluids; all the foregoing for use in disease detection, prevention and treatment in the fields of Covid-19, flu and related respiratory and medical conditions

Medical and laboratory diagnostic testing, monitoring and reporting services; medical services in the nature of administering vaccines and treatments; full line of medical diagnostic testing, including blood, urine, toxicology and pathology; all the foregoing for use in disease detection, prevention and treatment in the fields of Covid-19, flu and related respiratory and medical conditions

Research and development of new medical and therapeutical products and treatments; medical research and development of new medical and therapeutical products and treatments; scientific research and development services; pharmaceutical research and development services; all the foregoing for use in disease detection, prevention and treatment in the fields of Covid-19, flu and related respiratory and medical conditions
prophase global healthcare

General Information


Serial Number90756650
Word MarkPROPHASE GLOBAL HEALTHCARE
Filing DateSaturday, June 5, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, May 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements


Goods and ServicesVaccines and medical preparations for use in the treatment and prevention of Covid-19, flu and related respiratory and medical conditions; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids; diagnostic reagents for medicinal use; diagnostic biomarker reagents for medical purposes; medical diagnostic reagents and assays for testing body fluids for microorganisms; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents for the analysis of body fluids; all the foregoing for use in disease detection, prevention and treatment in the fields of Covid-19, flu and related respiratory and medical conditions
Goods and ServicesMedical and laboratory diagnostic testing, monitoring and reporting services; medical services in the nature of administering vaccines and treatments; full line of medical diagnostic testing, including blood, urine, toxicology and pathology; all the foregoing for use in disease detection, prevention and treatment in the fields of Covid-19, flu and related respiratory and medical conditions
NOT AVAILABLE"GLOBAL HEALTHCARE"
Goods and ServicesResearch and development of new medical and therapeutical products and treatments; medical research and development of new medical and therapeutical products and treatments; scientific research and development services; pharmaceutical research and development services; all the foregoing for use in disease detection, prevention and treatment in the fields of Covid-19, flu and related respiratory and medical conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProPhase Labs, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGarden City, NY 11530

Party NameProPhase Labs, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGarden City, NY 11530

Trademark Events


Event DateEvent Description
Wednesday, June 9, 2021NEW APPLICATION ENTERED
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 27, 2021ASSIGNED TO EXAMINER
Thursday, October 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 28, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 28, 2021NON-FINAL ACTION WRITTEN
Thursday, October 28, 2021NON-FINAL ACTION E-MAILED
Thursday, October 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 3, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 3, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, November 3, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 3, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, November 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 6, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, April 17, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 29, 2022SOU EXTENSION 1 FILED
Tuesday, November 29, 2022SOU EXTENSION 1 GRANTED
Thursday, December 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 31, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2023SOU EXTENSION 2 FILED
Wednesday, May 31, 2023SOU EXTENSION 2 GRANTED
Friday, June 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023SOU EXTENSION 3 GRANTED
Wednesday, November 29, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2023SOU EXTENSION 3 FILED
Friday, December 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 30, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 31, 2024SOU EXTENSION 4 FILED
Friday, May 31, 2024SOU EXTENSION 4 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED